Long-Term Evaluation (Efficacy and Safety) of Infliximab in the Treatment of Persistently Active Juvenile Idiopathic Arthritis (JIA), Refractory to Standard Treatments

Authors
Publication date
1 January 2005
Publisher
British Medical Association

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    AIR Universita degli studi di Milano

    redirect
    oaioai:air.unimi.it:2434/13736
    Last time updated on 06/03/2019